Gaurav K. Gulati

Rheumatology

4860 Y St Ste 100
Sacramento, CA 95817

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Inpatient Psychiatric Admission of a Durable Left Ventricular Assist Device Recipient: Multidisciplinary Care Plan and Policy Framework.

Inpatient Psychiatric Admission of a Durable Left Ventricular Assist Device Recipient: Multidisciplinary Care Plan and Policy Framework.

Journal: ASAIO journal (American Society for Artificial Internal Organs : 1992)

Published: May 21, 2026

Pulmonary wave intensity analysis to assess ventriculo-arterial interactions in cardiogenic shock.

Pulmonary wave intensity analysis to assess ventriculo-arterial interactions in cardiogenic shock.

Journal: JHLT open

Published: April 09, 2026

Istaroxime's Effect on Hemodynamics and Arrhythmias in Cardiogenic Shock: A Pooled Analysis of SEISMiC Trials.

Istaroxime's Effect on Hemodynamics and Arrhythmias in Cardiogenic Shock: A Pooled Analysis of SEISMiC Trials.

Journal: JACC. Heart failure

Published: January 27, 2026

Ocular Manifestations of Giant Cell Arteritis.

Ocular Manifestations of Giant Cell Arteritis.

Journal: Advances in ophthalmology and optometry

Published: September 17, 2025

Assessment of Ventriculo-Arterial Interactions in Early and Undifferentiated Pulmonary Hypertension Using Wave Intensity Analysis.

Assessment of Ventriculo-Arterial Interactions in Early and Undifferentiated Pulmonary Hypertension Using Wave Intensity Analysis.

Journal: Journal of the American Heart Association

Published: August 30, 2025

Haemodynamic effects of istaroxime in SCAI stage B HF-related cardiogenic shock: Insights from the SEISMiC trial.

Haemodynamic effects of istaroxime in SCAI stage B HF-related cardiogenic shock: Insights from the SEISMiC trial.

Journal: ESC heart failure

Published: August 20, 2025

Safety and efficacy intravenous istaroxime up to 60 hours for patients with pre-cardiogenic shock.

Safety and efficacy intravenous istaroxime up to 60 hours for patients with pre-cardiogenic shock.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: April 02, 2025

Recognition of the Large Ambulatory C2D Stage of Advanced Heart Failure-A Call to Action.

Recognition of the Large Ambulatory C2D Stage of Advanced Heart Failure-A Call to Action.

Journal: JAMA cardiology

Published: February 05, 2025

Systemic Circulation in Advanced Heart Failure and Cardiogenic Shock: State-of-the-Art Review.

Systemic Circulation in Advanced Heart Failure and Cardiogenic Shock: State-of-the-Art Review.

Journal: Circulation. Heart failure

Published: January 20, 2025

Pulsatile Vascular Afterload Measurement Improves Prediction of Right-Sided Heart Dysfunction in Undifferentiated and Left-Sided Pulmonary Hypertension.

Pulsatile Vascular Afterload Measurement Improves Prediction of Right-Sided Heart Dysfunction in Undifferentiated and Left-Sided Pulmonary Hypertension.

Journal: Journal of the American Heart Association

Published: November 22, 2024

The Association Between Pulmonary Vascular Resistance and Posttransplant Outcomes Differs by Left Ventricular Assist Device Status.

The Association Between Pulmonary Vascular Resistance and Posttransplant Outcomes Differs by Left Ventricular Assist Device Status.

Journal: ASAIO journal (American Society for Artificial Internal Organs : 1992)

Published: September 24, 2024

Safety and efficacy of up to 60 h of iv istaroxime in pre-cardiogenic shock patients: Design of the SEISMiC trial.

Safety and efficacy of up to 60 h of iv istaroxime in pre-cardiogenic shock patients: Design of the SEISMiC trial.

Journal: ESC heart failure

Published: September 10, 2024

Showing 1-12 of 61

Last Updated: 09/26/2026